drugset / Trial / NCT01423955
Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the potential of erythropoietin in reducing risk and degree of acute kidney injury after cardiac surgery.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-01
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erythropoietin zeta | Unknown | 400 iu/kg | — |